KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Outstanding
Ratios

Teva Pharmaceutical Industries (TEVA) Shares Repurchased: 2010-2015

Historic Shares Repurchased for Teva Pharmaceutical Industries (TEVA) over the last 3 years, with Dec 2015 value amounting to $878.0 million.

  • Teva Pharmaceutical Industries' Shares Repurchased rose 75.60% to $878.0 million in Q4 2015 from the same period last year, while for Dec 2015 it was $1.9 billion, marking a year-over-year increase of 93.88%. This contributed to the annual value of $439.0 million for FY2015, which is 12.20% down from last year.
  • According to the latest figures from Q4 2015, Teva Pharmaceutical Industries' Shares Repurchased is $878.0 million, which was up 300.00% from -$439.0 million recorded in Q1 2015.
  • In the past 5 years, Teva Pharmaceutical Industries' Shares Repurchased ranged from a high of $533,000.0 billion in Q1 2012 and a low of -$533,000.7 billion during Q2 2012.
  • Moreover, its 3-year median value for Shares Repurchased was $150.0 million (2013), whereas its average is $239.3 million.
  • Examining YoY changes over the last 5 years, Teva Pharmaceutical Industries' Shares Repurchased showed a top increase of 133,250,100.00% in 2012 and a maximum decrease of 561,053,233.68% in 2012.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Shares Repurchased stood at $1.6 billion in 2011, then climbed by 10.92% to $1.8 billion in 2012, then tumbled by 45.62% to $994.0 million in 2013, then slumped by 49.70% to $500.0 million in 2014, then surged by 75.60% to $878.0 million in 2015.
  • Its Shares Repurchased was $878.0 million in Q4 2015, compared to -$439.0 million in Q1 2015 and $500.0 million in Q4 2014.